心血管药物与口腔和肠道微生物群健康之间的双向关系:综合性审查
Gangani Dharmarathne1, Samia Kazi2,3, Shalinie King2,4
1Australian Laboratory Services Global, Water and Hydrographic, Hume, ACT 2620, Australia.
Microorganisms
|November 27, 2024
概括
心血管疾病 (CVD) 药物可以改变肠道和口腔微生物组,影响药物反应. 需要进一步的研究来了解这些相互作用,并个性化治疗以获得更好的患者结果.
科学领域:
- 微生物组研究的研究.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 心血管疾病 (CVD) 是全球疾病和死亡的主要原因.
- 在心血管疾病患者和健康个体之间观察到肠道和口腔微生物群的差异.
- 心血管疾病患者通常需要长期服用药物,其对微生物群的影响正在调查中.
研究的目的:
- 审查有关心血管药物与口腔和肠道微生物组之间相互作用的现有证据.
- 突出这些相互作用对药物代谢和患者反应的影响.
- 发现当前研究中的差距,并强调进一步研究的必要性.
主要方法:
- 关于研究心血管药物对肠道和口腔微生物群的影响的文献综述.
- 对特定药物类别 (如他类药物和β阻塞剂) 的研究进行分析.
- 综合有关微生物组失生症及其临床影响的发现.
主要成果:
- 某些心血管药物,特别是他类药物和β-阻断剂,与肠道和口腔微生物失调有关.
- 微生物组的改变会影响心血管疾病药物的新陈代谢和吸收,导致药物反应的多样化.
- 新出现的证据表明,微生物组变化与治疗疗效之间存在联系,需要个性化的方法.
结论:
- 心血管药物和微生物群之间的相互作用是治疗结果的关键因素.
- 了解这些相互作用对于开发心血管疾病管理中的个性化药物策略至关重要.
- 需要更多的研究来确定确定的因果关系和临床意义.
相关概念视频
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:27The Oral Microbiota
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
01:18Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:22Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...